Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Biological characteristics of bone marrow mesenchymal stem cells and JAK2 mutation in myeloproliferative neoplasms].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi - 1 Sept 2012

Tian Hong, Chen Guang-Hua, Xu Yang, Wang Rong-Xian, Qiao Man, Liu Hui-Wen, Wu De-Pei

Abstract excerpt

OBJECTIVE: To study the biological characteristics of bone marrow mesenchymal stem cells (BMSCs) and detect JAK2 mutation in BMSCs from myeloproliferative neoplasms (MPN) patients. METHODS: JAK2 V617F mutation and exon 12 mutation in 70 MPN patients' blood or bone marrow samples were detected. Isolated BMSCs were then characterized their phenotype, mesenchymal differentiation capacity and existence of JAK2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Bone Marrow Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bone Marrow Neoplasms

Share to DNA Mutational Analysis

Share to Janus Kinase 2

Share to Mesenchymal Stem Cells

Share to Myeloproliferative Disorders

Share to Young Adult

Source

Identifiers

PMID: 23336220
DOI: 10.3760/cma.j.issn.0253-2727.2012.09.003

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Biological characteristics of bone marrow mesenchymal stem cells and JAK2 mutation in myeloproliferative neoplasms].PMID 23336220Read ↗

[Progress of study on JAK2V617F mutation in myeloproliferative neoplasm].Semantic proximity Read ↗

Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesisSemantic proximity Read ↗

Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overviewSemantic proximity Read ↗

Detection Mutations of JAK2 exon 12 in Patients with JAK2 (V617F)-negative Myeloproliferative Disorders.Semantic proximity Read ↗

[Research progress on gene mutation of jak2].Semantic proximity Read ↗

[JAK2 mutation can be used in diagnosis of myeloproliferative diseases].Semantic proximity Read ↗

[Myeloproliferative neoplasms and endothelial progenitor cells].Semantic proximity Read ↗

[Myeloproliferative diseases caused by Jak2 gene mutation].Semantic proximity Read ↗

[Research advances in the role of JAK2 mutations in acute leukemia].Semantic proximity Read ↗

Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation.Semantic proximity Read ↗

[Real world data on myeloproliferative neoplasms in Japan].Semantic proximity Read ↗

[Detection and clinical significance of JAK2 mutation in 412 patients with chronic myeloproliferative neoplasms].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.